Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
E7438, EPZ-6438
print preview
bookmark
share with colleague
General Information
Company
Epizyme Inc.
Description
Selective inhibitor of enhancer of zeste homolog 2 (EZH2)
Molecular Target
Enhancer of zeste homolog 2 (EZH2)
Mechanism of Action
Latest Stage of Development
Preclinical
Indication
Lymphoma
Partner
Eisai Co. Ltd.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information